Literature DB >> 14662987

Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

James R Johnson1, Abby Gajewski, Alan J Lesse, Thomas A Russo.   

Abstract

Multiple Escherichia coli isolates from four adults with extraintestinal infections underwent molecular phylotyping and virulence profiling. A patient with secondary peritonitis had two low-virulence E. coli strains from phylogenetic groups A and D. In contrast, three patients with invasive extraurinary infections (septic arthritis/pyomyositis, nontraumatic meningitis/hematogenous osteomyelitis, and pneumonia) each had a single high-virulence phylogenetic group B2 strain resembling typical isolates causing urinary infection and/or sepsis, i.e., extraintestinal pathogenic E. coli.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662987      PMCID: PMC309005          DOI: 10.1128/JCM.41.12.5798-5802.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.

Authors:  T A Russo; J R Johnson
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

Review 2.  Extraintestinal pathogenic Escherichia coli: "the other bad E coli".

Authors:  James R Johnson; Thomas A Russo
Journal:  J Lab Clin Med       Date:  2002-03

3.  Identification of sat, an autotransporter toxin produced by uropathogenic Escherichia coli.

Authors:  D M Guyer; I R Henderson; J P Nataro; H L Mobley
Journal:  Mol Microbiol       Date:  2000-10       Impact factor: 3.501

4.  Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates: PCR assays for detection of Afa adhesins that do or do not recognize Dr blood group antigens.

Authors:  C Le Bouguénec; L Lalioui; L du Merle; M Jouve; P Courcoux; S Bouzari; R Selvarangan; B J Nowicki; Y Germani; A Andremont; P Gounon; M I Garcia
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection.

Authors:  Ming-Cheng Wang; Chin-Chung Tseng; Chiung-Yu Chen; Jiunn-Jong Wu; Jeng-Jong Huang
Journal:  Clin Infect Dis       Date:  2002-10-28       Impact factor: 9.079

6.  Risk and case fatality rate of meningitis in patients with liver cirrhosis.

Authors:  I Mølle; A M Thulstrup; N Svendsen; H C Schønheyder; H T Sørensen
Journal:  Scand J Infect Dis       Date:  2000

7.  Escherichia coli msbB gene as a virulence factor and a therapeutic target.

Authors:  J E Somerville; L Cassiano; R P Darveau
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

8.  Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia.

Authors:  J R Johnson; T T O'Bryan; M Kuskowski; J N Maslow
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 9.  Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

Authors:  Thomas A Russo; James R Johnson
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

10.  Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections.

Authors:  James R Johnson; Thomas A Russo
Journal:  J Infect Dis       Date:  2002-08-20       Impact factor: 5.226

View more
  36 in total

1.  Three-decade epidemiological analysis of Escherichia coli O15:K52:H1.

Authors:  Bente Olesen; Flemming Scheutz; Megan Menard; Marianne N Skov; Hans Jørn Kolmos; Michael A Kuskowski; James R Johnson
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

2.  Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection.

Authors:  James R Johnson; Connie Clabots; Henry Rosen
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Multispecies activity screening of microcin J25 mutants yields antimicrobials with increased specificity toward pathogenic Salmonella species relative to human commensal Escherichia coli.

Authors:  Seth C Ritter; Mike L Yang; Yiannis N Kaznessis; Benjamin J Hackel
Journal:  Biotechnol Bioeng       Date:  2018-07-20       Impact factor: 4.530

4.  Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype.

Authors:  James R Johnson; Brian Johnston; Michael A Kuskowski; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.

Authors:  Nao Matsuo; Rina Nonogaki; Michiko Hayashi; Jun-Ichi Wachino; Masahiro Suzuki; Yoshichika Arakawa; Kumiko Kawamura
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

6.  Potential pathogenicity and host range of extended-spectrum beta-lactamase-producing Escherichia coli isolates from healthy poultry.

Authors:  Valeria Bortolaia; Jesper Larsen; Peter Damborg; Luca Guardabassi
Journal:  Appl Environ Microbiol       Date:  2011-06-24       Impact factor: 4.792

Review 7.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

8.  Molecular analysis of antimicrobial-susceptible and -resistant Escherichia coli from retail meats and human stool and clinical specimens in a rural community setting.

Authors:  Elizabeth Lyon Hannah; James R Johnson; Frederick Angulo; Bassam Haddadin; Jacquelyn Williamson; Matthew H Samore
Journal:  Foodborne Pathog Dis       Date:  2009-04       Impact factor: 3.171

Review 9.  Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis.

Authors:  M Gousseff; F Lanternier; A Ferroni; O Chandesris; N Mahlaoui; O Hermine; O Lortholary; M Lecuit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-01       Impact factor: 3.267

10.  Signature-tagged mutagenesis in a chicken infection model leads to the identification of a novel avian pathogenic Escherichia coli fimbrial adhesin.

Authors:  Esther-Maria Antão; Christa Ewers; Doreen Gürlebeck; Rudolf Preisinger; Timo Homeier; Ganwu Li; Lothar H Wieler
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.